SEC Company Response from AtriCure, Inc. (ATRC) (CIK 0001323885) (ATRC) — Aug 3, 2005
AtriCure, Inc. (ATRC) (CIK 0001323885)
Date: Aug. 3, 2005 · CIK: 0001323885 · Accession: 0001193125-05-156621
AI Filing Summary & Sentiment
File numbers found in text: 333-124197
Letter
S.E.C. Correspondence
DIRECT:
(212) 351-4522
tpolin@ebglaw.com
August 3, 2005
VIA EDGAR AND FACSIMILE
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attn: Peggy A. Fisher, Assistant Director
Re: AtriCure, Inc.
File No. 333-124197
Ladies and Gentlemen:
Pursuant to our conversation this evening with Mary Beth Breslin, this letter shall confirm that David Drachman, President, Chief Executive Officer and a Director of AtriCure, Inc. (the “Company”), has advised us that he has no affiliations with any of the Company’s stockholders, including any of the Company’s “fund investors.”
Kindly contact the undersigned at (212) 351-4522 with any questions.
Very truly yours,
/s/ Theodore L. Polin
Show Raw Text
CORRESP 1 filename1.htm S.E.C. Correspondence DIRECT: (212) 351-4522 tpolin@ebglaw.com August 3, 2005 VIA EDGAR AND FACSIMILE Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attn: Peggy A. Fisher, Assistant Director Re: AtriCure, Inc. File No. 333-124197 Ladies and Gentlemen: Pursuant to our conversation this evening with Mary Beth Breslin, this letter shall confirm that David Drachman, President, Chief Executive Officer and a Director of AtriCure, Inc. (the “Company”), has advised us that he has no affiliations with any of the Company’s stockholders, including any of the Company’s “fund investors.” Kindly contact the undersigned at (212) 351-4522 with any questions. Very truly yours, /s/ Theodore L. Polin Theodore L. Polin cc: Mary Beth Breslin (via facsimile)